Predictors of Clinically Important Neuroimaging Findings in Children Presenting Pediatric Emergency Department


GÜNGÖR E., Haliloglu G., YALNIZOĞLU D., Oguz K. K., TEKŞAM Ö.

PEDIATRIC EMERGENCY CARE, sa.6, ss.474-479, 2024 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1097/pec.0000000000003203
  • Dergi Adı: PEDIATRIC EMERGENCY CARE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, MEDLINE
  • Sayfa Sayıları: ss.474-479
  • Hacettepe Üniversitesi Adresli: Evet

Özet

ObjectiveThe aim of the study is to evaluate predictors of clinically important neuroimaging results, that is, computed tomography and magnetic resonance imaging in children in an academic pediatric emergency department (PED) from 2015 to 2019.MethodsThis study was conducted in an academic PED. The patient's demographic and clinical characteristics of PED visits and neuroimaging findings requested at the PED were recorded for January 1, 2015, to December 31, 2019. In addition, descriptive statistics and logistic regression analyses were conducted. We described and determined the predictors of clinically important neuroimaging findings in children.ResultsClinically important neuroimaging findings were detected in patients with blurred vision (P = 0.001), ataxia (P = 0.003), unilateral weakness (P = 0.004), and altered level of consciousness (P = 0.026). Clinically important neuroimaging was found 9.4 times higher in patients with altered level of consciousness, 7.4 times higher in patients with focal weakness, 4.6 times higher in patients with blurred vision, and 3.5 times more in patients presenting with ataxia.ConclusionsAdvanced neuroimaging, especially for selected patients in PED, can improve the quality of health care for patients. On the other hand, irrelevant neuroimaging findings can lead physicians away from prompt diagnosis and accurate management. According to our study, advanced neuroimaging can be performed in the early period for both diagnosis and early treatment, especially in selected patients with ataxia, blurred vision, altered consciousness, and unilateral weakness. In other cases, clinicians may find more supporting evidence.